-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2025-02-21
3020-OL:HK:HK-X DBMSCIUSA (HKD)
COMMON STOCK | Other |
Last Closing
USD 1409.5Change
0.00 (0.00)%Market Cap
N/AVolume
165.00Analyst Target
N/A
N/A
Verdict
Values as of: 2025-02-21
COMMON STOCK | Other |
Last Closing
USD 1409.5Change
0.00 (0.00)%Market Cap
N/AVolume
165.00Analyst Target
N/AN/A
Verdict
There is no Profile data available for 3020-OL.HK.
Currency: HKD
Country : Hong Kong
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
0325:HK | Bloks Group Ltd |
+2.00 (+2.47%) |
USD 22.55B |
1863:HK | China Longevity Group Company .. |
N/A |
USD 1.17B |
8355:HK | I-CONTROL |
N/A |
USD 0.39B |
8343:HK | HongGuang Lighting Holdings Co.. |
+0.04 (+5.97%) |
USD 0.31B |
0648:HK | CHINA RENJ |
N/A |
USD 0.12B |
0542-OL:HK | CENERIC |
N/A |
N/A |
0240-OL:HK | BUILD KING HOLD |
-0.01 (-1.06%) |
N/A |
0546-OL:HK | Fufeng Group Ltd |
+0.09 (+1.65%) |
N/A |
0259-OL:HK | YEEBO (INT'L H) |
+0.04 (+2.41%) |
N/A |
0564-OL:HK | ZMJ |
-0.07 (-0.71%) |
N/A |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
DXZ:CA | Dynamic Active U.S. Mid-C.. | 11.35 % | 0.87 % |
-0.22 (-2.40%) |
CAD 0.04B |
IHF | iShares U.S. Healthcare P.. | 10.50 % | 0.43 % |
-1.82 (-2.40%) |
N/A |
TETF | 6.19 % | 0.64 % |
N/A |
N/A | |
BGU:CA | Bristol Gate Concentrated.. | 5.48 % | 0.85 % |
-0.85 (-2.40%) |
CAD 0.13B |
BGU-U:CA | Bristol Gate Concentrated.. | 5.48 % | 0.00 % |
-0.87 (-2.40%) |
CAD 0.11B |
FHI:CA | CI Health Care Giants Cov.. | 5.10 % | 0.75 % |
+0.04 (+-2.40%) |
CAD 0.10B |
FHI-B:CA | CI Health Care Giants Cov.. | 5.10 % | 0.00 % |
N/A |
CAD 0.05B |
MID | American Century Mid Cap .. | 4.56 % | 0.00 % |
-2.00 (-2.40%) |
USD 0.08B |
IAI | iShares U.S. Broker-Deale.. | 3.84 % | 0.42 % |
-2.98 (-2.40%) |
N/A |
CBUF:XETRA | 2.93 % | 0.00 % |
N/A |
N/A | |
HDIV | 2.83 % | 0.00 % |
N/A |
N/A | |
RYH | 1.72 % | 0.40 % |
N/A |
N/A | |
DSTL | Distillate US Fundamental.. | 1.67 % | 0.00 % |
-1.08 (-2.40%) |
USD 2.09B |
HONR | 1.20 % | 0.65 % |
N/A |
N/A | |
SMD | 0.45 % | 0.10 % |
N/A |
N/A | |
ESGL | ESGL Holdings Limited Ord.. | 0.00 % | 0.40 % |
-0.13 (-2.40%) |
USD 0.04B |
JKH | iShares Morningstar Mid-C.. | 0.00 % | 0.30 % |
N/A |
N/A |
RYF | 0.00 % | 0.40 % |
N/A |
N/A | |
VVL:CA | Vanguard Global Value Fac.. | 0.00 % | 0.40 % |
-0.62 (-2.40%) |
N/A |
WBIF | WBI BullBear Value 3000 E.. | 0.00 % | 1.05 % |
-0.49 (-2.40%) |
N/A |
XXM:CA | 0.00 % | 0.68 % |
N/A |
N/A | |
FSWD:LSE | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
-1.00 (-2.40%) |
N/A |
IFSW:LSE | iShares Edge MSCI World M.. | 0.00 % | 0.00 % |
N/A |
N/A |
IBCZ:F | 0.00 % | 0.00 % |
N/A |
N/A | |
IS07:F | 0.00 % | 0.00 % |
N/A |
N/A | |
IS07:XETRA | 0.00 % | 0.00 % |
N/A |
N/A | |
IMCG | iShares Morningstar Mid-C.. | 0.00 % | 0.00 % |
-1.89 (-2.40%) |
N/A |
Market Performance vs. Industry/Classification (Other) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 3.72% | 64% | D | 62% | D | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 3.72% | 64% | D | 62% | D | ||
Trailing 12 Months | |||||||
Capital Gain | 21.67% | 71% | C- | 71% | C- | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 21.67% | 68% | D+ | 69% | C- | ||
Trailing 5 Years | |||||||
Capital Gain | 94.55% | 80% | B- | 92% | A | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 94.55% | 80% | B- | 90% | A- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 17.32% | 77% | C+ | 76% | C+ | ||
Dividend Return | 17.32% | 75% | C | 75% | C | ||
Total Return | N/A | N/A | N/A | N/A | N/A | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 20.15% | 76% | C+ | 74% | C | ||
Risk Adjusted Return | 85.93% | 98% | N/A | 97% | N/A | ||
Market Capitalization | N/A | N/A | N/A | N/A | N/A |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
There is nothing we particularly dislike